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ABSTRACT
Background: Elevated maternal blood glucose concentrations may
contribute to macrosomia, adiposity, and poorer vascular health in
the offspring.
Objective: The aim was to explore the effect of a low–glycemic
index (low-GI) diet during pregnancy on offspring growth, adipos-
ity, and arterial wall thickness during infancy.
Design: This was a longitudinal follow-up study in a self-selected
subgroup of mother-infant pairs (n = 59) participating in a larger
randomized trial comparing the effects on perinatal outcomes of
a low-GI diet and a conventional high-fiber (HF) diet during preg-
nancy. Infant anthropometric measurements were taken every
month for 6 mo and then at 9 and 12 mo of age. Adiposity was
assessed at birth and at 3 mo by air-displacement plethysmography
by using the Pea Pod system (Cosmed) and at 6 and 12 mo by
bioimpedance analysis (Bodystat). Aortic intima-media thickness
was assessed at 12 mo by high-resolution ultrasound (Philips).
Results:Maternal dietary GI was lower in the low-GI group than in
the HF group (51 6 1 compared with 57 6 1; P , 0.001). No
differences in neonatal outcomes were observed in the main trial. In
the self-selected subsample, birth weight and length z scores were
lower in the low-GI group than in the HF group (birth weight z
score: 0.2 6 0.2 compared with 0.7 6 0.2, respectively; P = 0.04;
birth length z score: 0.3 6 0.2 compared with 0.9 6 0.2, respec-
tively; P = 0.04), but adiposity from birth to 12 mo of age and
growth trajectories from 1 to 12 mo of age were similar. Aortic
intima-media thickness was lower in the low-GI group than in the
HF group (657 612 compared with 696 6 12 mm, respectively; P =
0.02), which was partly mediated by differences in birth weight.
Conclusion: In women at risk of gestational diabetes mellitus,
a low-GI diet influences offspring birth weight, birth length, and
arterial wall thickness in early childhood, but not adiposity or
growth trajectory during the first year of life. This trial was regis-
tered at anzctr.org.au as ACTRN12610000681055. Am J
Clin Nutr 2016;103:1073–82.
Keywords: body composition, gestational diabetes mellitus, gly-
cemic index, infant, intima-media thickness
INTRODUCTION
High birth weight, adiposity, and rapid weight gain in infancy
have been identified as early predictors for obesity, metabolic
disorders, and atherosclerotic vascular disease in adult life (1–3).
Evidence in humans and animals supports the hypothesis that
elevated maternal blood glucose concentrations may link these
indicators of excessive early-life growth with metabolic disor-
ders and poor vascular health in the offspring (4–6). Pregnancy
is characterized by a state of physiologic insulin resistance,
enabling sufficient substrate delivery to the fetus. Intrauterine
overnutrition through maternal impaired glucose metabolism
has been shown to increase fetal and childhood adiposity (7, 8).
Excessive fetal and infant growth has further been associated
with structural manifestations of atherosclerosis in early child-
hood and across the life span (3, 6, 9, 10). Importantly, the
consequences of maternal glucose concentrations on fetal
growth do not occur at definite thresholds but rather across
a continuum (11).
Interventions that lower elevated maternal blood glucose
concentrations have been shown to improve perinatal outcomes
(12). Maternal diet, particularly the type and amount of carbo-
hydrate, influences maternal postprandial blood glucose con-
centrations and, hence, potentially affects fetal overnutrition and
adiposity (7, 13). Low–glycemic index (low-GI)11 foods produce
lower postprandial increases in blood glucose and reduce diurnal
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postprandial glucose and insulin responses compared with high-
GI foods (14–16). Because glucose is the principal substrate for
fetal growth, low-GI diets might be of particular relevance
during pregnancy. Nonetheless, results of randomized controlled
trials (RCTs) are mixed with regard to whether a low-GI diet
during pregnancy affects birth weight (13, 17–20).
The effects of a low-GI diet during pregnancy on offspring
growth and vascular health beyond the immediate postnatal
period have not been studied in the context of a RCT. The aim of
this study was therefore to determine the potential longer-term
effects of a low-GI diet compared with a conventional moderate-
GI, high-fiber (HF) diet on infant growth, body composition, and
aortic intima-media thickness (IMT). We focused on mothers
identified clinically as being at risk of developing gestational
diabetes mellitus (GDM), because this group is more likely to
show elevated blood glucose concentrations than other pregnant
women. We hypothesized that infants born to mothers at high risk
of developing GDM randomly assigned to receive the low-GI diet
would have lower adiposity and growth velocity from birth to
12 mo and reduced aortic IMT at 1 y of age.
METHODS
The GI Baby 4 Study was a pilot prospective follow-up study
exploring the growth velocity and body composition of the in-
fants born to mothers enrolled in the GI Baby 3 Study, a 2-arm
RCT assessing the effects of a low-GI diet compared with a
conventional HF diet during pregnancy on perinatal outcomes
(20). For the GI Baby 3 Study, singleton pregnant women (week
12–20 of gestation) were recruited from the antenatal clinic at
the Royal Prince Alfred Hospital, Sydney, Australia. They were
eligible if they had at least one of the following risk factors:
prepregnancy BMI (in kg/m2) $30, age $35 y, polycystic ovary
syndrome, previous history of GDM or glucose intolerance,
history of a previous newborn weighing.4000 g, family history
of type 2 diabetes (first-degree relative), or belonging to an
ethnic group with a high prevalence of GDM (Aboriginal, Torres
Strait Islander, Polynesian, Middle Eastern, Indian, or Asian).
Women with special dietary requirements (gluten-intolerant,
celiac disease) or pre-existing diabetes were excluded. For the
GI Baby 4 Study, eligible participants were infants ($36 wk of
gestation) with no congenital defects or metabolic disturbances
influencing growth. Recruitment for the GI Baby 4 Study
spanned the period June 2011 to February 2013, and data col-
lection ended in March 2014. The study was in accordance with
the ethical standards of the Human Research Ethics Committee
of the Sydney South West Area Health Service (RPAH Zone,
reference no. HREC/11/RPAH/190). Parental informed written
consent was obtained, and participation was voluntary.
Maternal demographic characteristics, perinatal outcomes, and
dietary intake during pregnancy were collected as part of the GI
Baby 3 Study, as previously described (20). Glucose, lipids, and
fructosamine were measured by using standard enzymatic
techniques (Roche Cobas C702). Insulin was measured by im-
munoassay (Abbott Architect i2000SR). Adiponectin was mea-
sured by radioimmunoassay (Millipore HADP-61K). GDM
diagnosis was based on modified 1998 Australasian Diabetes in
Pregnancy Society Australian criteria, as follows: fasting blood
glucose concentrations $5.5 mmol/L, 1-h blood glucose con-
centration of $10.0 mmol/L, or 2-h blood glucose concentration
of $8.0 mmol/L (21). HOMA-IR was calculated as follows
(22): [fasting insulin (mU/mL)] 3 [fasting glucose (mmol/L)]/
22.5. The maternal insulin sensitivity index was calculated ac-
cording to the Matsuda and DeFronzo formula (23). Maternal
BMI was calculated by dividing self-reported prepregnancy
weight by measured height squared. Gestational weight gain was
computed as the difference between measured weight at week
34–36 of gestation and self-reported prepregnancy weight and
categorized according to the 2009 Institute of Medicine rec-
ommendations on weight gain during pregnancy (24). Dietary
data (2 weekdays and 1 weekend day) were collected by using
estimated 3-d food records at baseline (12–20 wk of gestation)
and at the end of the intervention (34–36 wk of gestation). Di-
etary GI values were assigned to carbohydrate food items with
the use of published sources (25) and the University of Sydney
GI Research Service database. Dietary data were analyzed with
the software FoodWorks 7 Professional (Xyris Software), based
on the Australian food-composition database AUSNUT2007.
Infant anthropometric and body-composition
measurements
Birth weight, length, and head circumference were obtained
from medical records. Gestational age was estimated from the
date of last menstrual period and early pregnancy ultrasound.
Infant anthropometric measurements were taken every month
for the first 6 mo and then at 9 and 12 mo of age. Measurements
were taken at the Human Nutrition Unit of the University of
Sydney. A nude weight was obtained to the nearest 0.01 kg by
using an electronic scale (Tanita BD-590 pediatric scale).
Recumbent length was measured heel to crown to the nearest
0.1 cm by using an infant length board (Seca 416 infantometer).
Head circumference and abdominal girth were measured to the
nearest 0.1 cm by using a flexible nonstretchable measuring
tape (Seca 212 measuring tape). Measures were taken in
duplicate and averaged. A third measurement was performed if
results differed by .1.0 cm, and the average of the 2 nearest
measurements was used. In unsettled infants, these measure-
ments were taken once only.
Weight-for-age z score (WAZ), length-for-age z score (LAZ),
weight-for-length z score, and BMI-for-age z score were cal-
culated by using a sex-specific reference database from the
WHO (Anthro 3.0.1 software) (26). Ponderal index was calcu-
lated as birth weight (g)/length (cm)3 3 100. Birth weight
centile was calculated by using a macro program from Microsoft
Excel (available from http://www.gestation.net) and was used to
categorize infants as small-for-gestational-age (birth weight
,10th centile) or large-for-gestational-age (birth weight .90th
centile). Body composition was assessed within 48 h after
birth and at 3 mo of age by using Pea Pod (Cosmed), an air-
displacement plethysmography device previously validated in
infants (27).
At 6 and 12 mo of age, body composition was assessed by
multifrequency bioimpedance (Quadscan 4000 Bodystat),
a noninvasive technique that derives a 2-compartment model of
body composition by measuring the body impedance to a mul-
tifrequency electric current (5, 50, 100, and 200 kHz) that passes
through the body. Infants were lightly dressed and lay in the
supine position on a mattress. Skin sites were first cleaned with
alcohol wipes. Two pairs of self-adhesive electrodes (Skintact
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Easitabs RT14; Leonhard Lang GmbH) were placed on the infant.
One pair was placed on the dorsal surface of the right hand, one
on the distal metacarpal joints, and one between the right radius
and ulna. The second pair of electrodes was placed on the dorsal
surface of the right foot, one at the distal metatarsal joints and one
between the lateral malleoli. Infant percentage fat mass (FM) was
obtained by using the 50-kHz raw data fitted by using the Cole
fitting method. Infant adiposity is also expressed as FM index,
calculated as FM (kg)/length (m)2 (28).
Infant aortic IMT
At 12 mo of age, aortic IMT was measured in a straight,
nonbranched longitudinal segment of the proximal abdominal
aorta by high-resolution ultrasound (Philips iE33; Philips), as
previously described (29, 30). The aortic IMT (the distance from
the lumen-intima interface to the media-adventitia interface)
was quantified by using semiautomated and validated offline
software (Carotid Analyzer; Medical Imaging Applications) in
a 0.5- to 1-cm-long segment of the dorsal aortic wall, from
2 loops of $40 frames each. Both the sonographer (MRS) and
reader (YK) were blinded to participant identity, characteris-
tics, and study group. These methods for the measurement and
analysis of the IMT have been used previously by our research
team (30, 31) and have been shown to be highly reproducible
(30). Aortic IMT assessed by high-resolution ultrasound is
currently considered to be the most sensitive noninvasive
measure of structural changes to the arterial vasculature con-
sistent with the earliest physical manifestations of atheroscle-
rosis (29). This technique enables the identification of putative
risk factors in infants, with findings thus far being consistent
with those derived from direct histologic examination in post-
mortem studies (9, 30, 32).
Infant feeding practice
Information on the duration of breastfeeding and solid food in-
troduction was collected at each visit by questionnaire.Mothers were
asked, “How old was your baby when [child] completely stopped
breastfeeding?” Possible answers were “still breastfeeding,” “child’s
age (days/weeks/months) when stopped breastfeeding,” and “never
breastfed.” Mothers were also asked, “How old was your baby when
[child] first regularly had solid food?” Possible answers were
“child’s age (days/weeks/months) when solid food was started” and
“never given solid food.” This variable was treated as a categorical
variable, such as exclusively breastfed, breastfed, weaned, or never
breastfed. The term “exclusive breastfeeding” referred to infants
who received only breast milk and no other liquids or solid foods,
with the exception of medicines. The duration of exclusive breast-
feeding was defined as the time from birth until introduction of
FIGURE 1 Participant flow diagram. GI, glycemic index.
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TABLE 1
Maternal characteristics and pregnancy outcomes1
Low-GI group HF group
n Value n Value P
Age at study entry, y 30 34.9 6 0.8 29 35.5 6 0.7 0.587
Prepregnancy BMI, kg/m2 30 25.8 6 1.0 29 25.9 6 1.0 0.988
Ethnicity, % 30 29 0.359
Asian 20 14
White 63 80
Others 17 7
Employment, % 30 29 0.370
Full-time 67 66
Part-time 17 28
Unemployed 17 7
Education, % 30 29 0.357
Secondary 13 14
Tertiary 53 55
Postgraduate 23 31
Parity ($1), % 30 50 29 62 0.502
Gestational weight gain, kg 30 10.6 6 1.0 29 10.7 6 1.0 0.949
IOM weight gain range, % 30 29 0.293
Below 50 31
Within 23 38
Above 27 31
Delivery, % 30 29 0.348
Vaginal 70 69
Elective cesarean 17 7
Emergency cesarean 13 24
GDM, % 30 27 29 31 0.711
Insulin use, % 30 20 29 14 0.747
Adiponectin,2 mmol/L 30 13.6 6 1.3 28 13.8 6 1.2 0.881
Fructosamine,2 mmol/L 17 188.6 6 4.6 14 196.2 6 4.1 0.236
Total cholesterol,2 mmol/L 30 5.2 6 0.2 28 5.5 6 0.2 0.242
Triglycerides 30 1.2 6 0.1 28 1.3 6 0.1 0.437
HDL cholesterol 30 2.0 6 0.1 29 2.1 6 0.1 0.451
LDL cholesterol 30 2.7 6 0.1 29 2.7 6 0.2 0.910
HbA1c2
% 30 5.0 6 0.7 28 5.0 6 0.6 0.865
mmol/L 30 31.0 6 7.7 28 31.0 6 6.6
Glucose,2 mmol/L
Fasting 30 4.4 6 0.1 29 4.4 6 0.1 0.886
30 min 26 7.0 6 0.3 24 7.3 6 0.2 0.423
60 min 30 6.8 6 0.3 29 7.2 6 0.3 0.413
120 min 30 6.0 6 0.3 29 6.2 6 0.3 0.722
Insulin,2 pmol/L
Fasting 30 36 6 3 25 42 6 4 0.214
30 min 26 290 6 23 24 359 6 41 0.136
60 min 29 257 6 23 24 408 6 55 0.009
120 min 29 203 6 22 24 351 6 58 0.023
HOMA-IR2 30 1.0 6 0.1 25 1.2 6 0.1 0.329
ISI2 29 11.2 6 1.0 24 8.0 6 1.0 0.017
GDM risk factors, %
Age .35 y 30 53.3 29 65.5 0.341
Family history of T2D 30 63.3 29 37.9 0.051
Previous newborn .4000 g 30 6.7 29 10.3 0.612
Ethnicity3 30 23.3 29 17.2 0.561
BMI .30 kg/m2 30 20.0 29 10.3 0.302
Previous GDM 30 13.3 29 10.3 0.723
PCOS 27 0 29 7.1 0.157
1Values are means 6 SEMs for continuous variables and percentages for categorical variables. P values were derived by
2-sample t test or chi-square test. GDM, gestational diabetes mellitus; GI, glycemic index; HbA1c, glycated hemoglobin; HF,
high fiber; IOM, Institute of Medicine; ISI, insulin sensitivity index; PCOS, polycystic ovary syndrome; T2D, type 2 diabetes.
2Measured at baseline (12–20 wk of gestation).
3High-risk ethnicities include Aboriginal or Torres Strait Islander, Polynesian, Middle Eastern, Indian, and Asian.
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non–breast milk or any solid. The term “breastfeeding” referred to
infants who received breast milk, in combination with other liquids.
Statistical analysis
Descriptive data are presented as means6 SEMs for continuous
variable and numbers (n) and percentages for frequency variables
unless otherwise stated. Data were assessed for normality. Differ-
ences between dietary groups were determined by using an
independent-samples t test for continuous variables and chi-square
test for categorical variables. Associations between dietary groups
and infant anthropometric and body-composition measurements at
birth were investigated by using linear regression, adjusting for
maternal prepregnancy BMI, gestational weight gain, and GDM
unless otherwise stated. Associations between dietary groups and
infant body composition at 3, 6, and 12 mo of age were in-
vestigated by using linear regression. The model was adjusted
for maternal prepregnancy BMI, gestational weight gain,
gestational age, GDM, sex, and infant feeding practice. Linear
mixed models were used to assess differences in growth velocity
between the 2 diet groups. This approach allows for intrasubject
correlation of repeated measures on subjects and accounts for an
unbalanced design in the number of observations and the age (time)
at which they were collected. Models were fitted for the infancy
period from birth to 12 mo of age, with birth and 3-, 6-, 9-,
and 12-mo growth measurements included in the model. Models
were adjusted for maternal prepregnancy BMI, gestational weight
gain, GDM, and infant feeding practice. As a pilot study, it was not
powered to detect significant differences in the primary outcome
(body composition at 12 mo) but rather to explore the feasibility
of carrying out an RCT examining the efficacy of a low-GI diet on
offspring growth, metabolism, and vascular health. Statistical
analysis was undertaken with the use of IBM SPSS Statistics
(version 21; IBM Corporation), and significance was inferred at
a 2-sided P value ,0.05.
RESULTS
A total of 125 subjects completed the GI Baby 3 Study and 105
infants met the inclusion criteria for the GI Baby 4 Study. Of
these, 59 mother-infant pairs agreed to join the GI Baby 4 Study:
30 from the low-GI group and 29 from the HF group (Figure 1).
Mothers who participated in the follow-up study were more
likely to be white (71% compared with 45.5%; P = 0.01), have
a lower dietary GI at baseline (55 6 5 compared with 58 6 6;
P = 0.007), have higher fiber intakes at the end of the in-
tervention (28.4 6 7.6 compared with 25.3 6 8.5 g; P = 0.04),
and deliver infants who were heavier (3.5 6 0.5 compared with
3.36 0.4 kg; P = 0.05) and longer at birth (50.56 1.9 compared
with 49.7 6 1.8 cm; P = 0.01) compared with those who de-
clined to participate in the follow-up study. Of the 59 mother-
infant pairs who participated in the follow-up study, 49 infants
completed the 12-mo assessment. Baseline characteristics are
presented in Table 1. There were no significant differences in
maternal characteristics, including risk factors for GDM, fasting
and postchallenge glucose concentrations, fasting insulin, and
HOMA-IR between those randomly assigned to the low-GI
compared with the HF intervention. However, women in the HF
group had a significantly lower insulin sensitivity index, indic-
ative of a lower composite hepatic and peripheral insulin sen-
sitivity, and higher post–glucose load insulin concentrations at
baseline.
Maternal dietary intake during pregnancy
At baseline (12–20 wk of gestation), no significant differences
were observed between the 2 groups in total energy intake and
macronutrient distribution (Table 2). At the end of the inter-
vention (34–36 wk of gestation), as per protocol, dietary GI was
significantly lower in the low-GI group than in the HF group
(low-GI compared with HF group: 516 1 compared with 576 1;
P , 0.001). The overall ratio of carbohydrates, protein, and fats
TABLE 2
Maternal diet at baseline and at the end of the intervention1
Baseline End of intervention P3
Low-GI
group HF group P2
Low-GI
group HF group P2
Low-GI
group
HF
group
n 30 29 28 26 — — —
Energy, kJ 8900 6 270 8890 6 325 0.976 8480 6 290 8390 6 260 0.816 0.171 0.181
Protein, g 98 6 4 96 6 4 0.719 98 6 4 94 6 4 0.516 0.891 0.804
Total fat, g 78 6 4 83 6 4 0.400 78 6 4 78 6 4 0.918 0.923 0.231
Saturated fat, g 30 6 2 32 6 2 0.555 27 6 2 30 6 2 0.175 0.144 0.247
Total available carbohydrate, g 245 6 9 235 6 10 0.454 219 6 9 218 6 10 0.987 0.010 0.192
Sugars, g 105 6 6 96 6 6 0.288 91 6 6 97 6 7 0.554 0.107 0.977
Starch, g 137 6 7 138 6 7 0.979 126 6 5 120 6 6 0.445 0.053 0.030
Fiber, g 27 6 2 27 6 2 0.805 30 6 2 27 6 1 0.075 0.179 0.728
GI 55 6 1 56 6 1 0.330 51 6 1 57 6 1 ,0.001 0.002 0.253
Glycemic load 126 6 6 123 6 6 0.659 105 6 5 117 6 6 0.115 ,0.001 0.523
Protein, % of energy 19 6 1 19 6 1 0.739 20 6 1 19 6 1 0.623 0.441 0.315
Total fat, % of energy 32 6 1 34 6 1 0.126 34 6 1 34 6 1 0.652 0.287 0.563
Saturated fat, % of energy 12 6 1 13 6 1 0.351 11 6 1 13 6 1 0.029 0.289 0.708
Carbohydrate, % of energy 45 6 1 44 6 1 0.245 43 6 1 43 6 1 0.942 0.075 0.787
1Values are means 6 SEMs unless otherwise indicated. GI, glycemic index; HF, high fiber.
2Obtained by 2-sample t test to test differences between groups.
3Obtained by paired-sample t test to test for differences compared with baseline.
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was similar, but the percentage of energy from saturated fat was
significantly lower in the low-GI group (low-GI compared with
HF group: 11% 6 1% compared with 13% 6 1%; P = 0.03).
From baseline to the end of the intervention, there was a sig-
nificant decrease in starch intake in the HF group and a signifi-
cant decrease in dietary GI and glycemic load in the low-GI
group (Table 2).
Maternal dietary GI in pregnancy and infant growth and
arterial wall thickness
Infant anthropometric measurements at birth and body com-
position assessed at birth and 3, 6, and 12 mo of age are presented
in Table 3. A sensitivity analysis revealed 2 outliers (1 male
infant with a birth weight ,2.5 kg and 1 female infant with an
LAZ .3 SDs from the mean). Results are therefore presented
for 57 infants: 28 in the low-GI group and 29 in the HF group.
Gestational age was similar in both groups. Infant birth weight,
birth length, WAZ, and LAZ were significantly higher in the HF
group. In the model that adjusted for maternal prepregnancy
BMI, gestational weight gain, and GDM, WAZ and LAZ re-
mained significantly different between the 2 groups. When the 2
outlier infants were included in the analysis, only mean WAZ
remained significantly different between the 2 groups (low-GI
compared with HF group: 0.1 6 0.2 compared with 0.7 6 0.2;
P = 0.03).
After birth, infant growth trajectories did not differ between
the 2 groups (Figure 2). Head circumference and abdominal
girth growth velocities did not differ between the 2 groups (data
not shown). Data on infant feeding practice showed that, at 3 mo
of age, 84% of the infants were exclusively breastfed, which
decreased to 17% at 6 mo of age. At 12 mo of age, 78% of the
infants were still breastfed.
TABLE 3
Neonatal anthropometric measurements and infant body composition in the first year of life1
Low-GI group HF group
n Value n Value P P-adjusted2
Birth
Female, n (%) 28 15 (54) 29 18 (62) — —
Gestational age, wk 28 39.4 6 0.3 29 39.9 6 0.2 0.141 0.113
Weight, kg 28 3.4 6 0.1 29 3.6 6 0.1 0.040 0.1003
Length, cm 28 50 6 0.3 29 51 6 0.3 0.019 0.0683
Head circumference, cm 27 34.3 6 0.2 27 34.9 6 0.3 0.067 0.1443
Ponderal index, kg/m3 28 2.7 6 0.0 29 2.7 6 0.1 0.836 0.7403
Birth weight centile 28 40.1 6 4.3 29 48.1 6 5.0 0.230 NA
Small-for-gestational-age, n (%) 28 3 (10.7) 29 2 (6.9) 0.336 NA
Large-for-gestational-age, n (%) 28 0 (0.0) 29 2 (6.9) — —
Weight-for-age z score 28 0.2 6 0.2 29 0.7 6 0.2 0.035 0.037
Weight-for-length z score 28 0.1 6 0.2 29 0.1 6 0.2 0.992 0.993
Length-for-age z score 28 0.3 6 0.2 29 0.9 6 0.2 0.013 0.016
BMI-for-age z score 28 0.1 6 0.2 29 0.3 6 0.2 0.315 0.307
Fat mass,4 % 24 9.8 6 1.0 21 10.9 6 0.7 0.393 0.5033
Fat mass index4 24 1.3 6 0.1 21 1.4 6 0.1 0.450 0.5213
3 mo
Female, n (%) 28 15 (54) 26 17 (65) — —
Weight, kg 28 6.1 6 0.1 26 6.2 6 0.2 0.706 0.7635
Fat mass, % 28 25.2 6 1 26 24.6 6 0.9 0.681 0.4515
Fat mass index 28 7.0 6 0.3 26 6.8 6 0.3 0.489 0.4285
6 mo
Female, n (%) 27 14 (51.9) 24 16 (66.7) — —
Weight, kg 27 7.8 6 0.2 24 7.7 6 0.2 0.785 0.963
Fat mass,6 % 27 30.0 6 0.8 23 31.1 6 0.8 0.344 0.6465
Fat mass index6 27 5.4 6 0.2 23 5.4 6 0.2 0.922 0.8925
12 mo
Female, n (%) 25 14 (56) 22 14 (63.6) — —
Weight, kg 25 9.7 6 0.2 22 9.7 6 0.2 0.955 0.862
Fat mass,7 % 24 33.6 6 0.7 20 34.4 6 0.5 0.464 0.4495
Fat mass index7 24 5.9 6 0.2 20 6.0 6 0.2 0.671 0.6555
1Values are means 6 SEMs for continuous variables and n (%) for categorical variables. Groups were compared by
using independent-samples t test. GDM, gestational diabetes mellitus; GI, glycemic index; HF, high fiber; NA, not
applicable as centile accounts for maternal height, weight, ethnicity, parity, infant sex, gestational age, and birth weight.
2P values adjusted for maternal prepregnancy BMI, gestational weight gain, and GDM unless otherwise indicated.
3Adjusted for maternal prepregnancy BMI, gestational weight gain, GDM, gestational age, and sex.
4Available data in 12 and 13 female infants in the low-GI and HF groups, respectively.
5Adjusted for maternal prepregnancy BMI, gestational weight gain, GDM, gestational age, sex, and feeding practice.
6Available data in 14 and 15 female infants in the low-GI and HF groups, respectively.
7Available data in 14 and 13 female infants in the low-GI and HF groups, respectively.
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Post hoc multivariable linear regression analysis showed no
association of maternal GI at 36 wk of gestation with offspring
aortic IMT at 12 mo (21 mm; 95% CI: 25, 3 mm; P = 0.60);
however, aortic IMT was significantly thinner in the low-GI
group compared with the HF group (low-GI compared with
HF group: 657 6 12 compared with 696 6 12 mm; P = 0.02)
(Figure 3). Adjustment for birth weight marginally reduced
the estimated effect size (low-GI compared with HF group:
661 6 11 compared with 692 6 11 mm; P = 0.07). Maximum
aortic IMT showed greater variability per se, and the differ-
ence between groups was not significant (low-GI compared
with HF group: 842 6 17 compared with 882 6 17 mm; P =
0.11).
DISCUSSION
To our knowledge, this is the first RCT to assess the effects of
a low-GI diet during pregnancy on offspring growth and adiposity
beyond birth. In women at risk of GDM, we found that, relative to
a conventional healthy diet, a low-GI dietary intervention resulted
in lower infant WAZ and LAZ at birth, thereby more closely
resembling population norms (the 50th percentile). There was no
evidence of differences in adiposity at birth or in postnatal growth
trajectories from 1 to 12 mo of age. Hence, mothers randomly
assigned to receive a lower-GI diet during pregnancy gave birth to
smaller, but not leaner, infants. Nonetheless, the infants of
mothers who consumed a lower-GI diet had thinner aortic walls at
12 mo of age than the offspring of mothers who consumed
a conventional HF diet with a higher GI.
The smaller aortic IMT in the low-GI group provides proof-of-
concept that a dietary intervention initiated during pregnancy
may partially mitigate the vascular sequelae of maternal hy-
perglycemia, even within the normal range. The women recruited
were considered “at risk” of developing GDM. There is good
evidence that the children of these women are also likely, on
average, to have thicker aortic IMT on the basis of a higher
incidence of GDM and high birth weight (3, 6) and a greater
prevalence of maternal obesity (31). Interestingly, others pre-
viously showed that the thicker aortic IMT in the macrosomic
infants of mothers with GDM appears to be independent of their
FIGURE 2 Effects of a low-GI compared with an HF diet during pregnancy on offspring postnatal growth trajectory from birth to 12 mo of age. Values are
estimated marginal means 6 SEMs obtained from linear mixed models for the low-GI and HF groups. Models adjusted for maternal prepregnancy BMI,
gestational weight gain, GDM, and infant feeding practice. Missing values were extrapolated by the model (n = 57: 28 in the low-GI group and 29 in the HF
group). (A) Weight-for-age z score trajectories from birth to 12 mo of age; (B) length-for-age z score trajectories from birth to 12 mo of age; (C) weight-for-length
z score trajectories from birth to 12 mo of age; (D) BMI-for-age z score trajectories from birth to 12 mo of age. GI, glycemic index; HF, high-fiber.
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birth weight (6). Indeed, the observed difference in aortic IMT
was predominantly independent of birth weight, suggesting
that a maternal low-GI diet during pregnancy improves off-
spring vascular health via mechanisms that are not reflected
by modification of birth weight. Putative mechanisms include
epigenetic modifications or changes in the number and
function of endothelial progenitor cells (33). Other dietary
factors, such as saturated fat intake, may be implicated. Fu-
ture studies should investigate maternal and infant markers
that are closely associated with improvements in vascular
health, including detailed analyses of maternal and infant
dietary intake.
Our findings in relation to size at birth (i.e., significantly larger
offspring in mothers randomly assigned to receive the HF diet)
contrast with the findings in the entire GI Baby 3 cohort, in which
no significant effects were evident (20). However, our results are
consistent with other studies that reported lower birth weight
among infants of women who consumed a low-GI diet during
pregnancy (13, 17). We initially speculated that the mechanism
through which a low-GI diet would result in normalization of
offspring birth WAZ and LAZ may involve reduced maternal
postprandial increases in glucose, lessening the availability of
glucose to the fetus and thus normalizing fetal glycemia and
insulin production (11, 34–36). However, the difference may
also be attributable to the characteristics of the mothers who,
after participating in the original trial, self-selected to participate
in the follow-up study reported here. In general, women who
were willing to continue participation beyond birth were highly
educated and had a lower dietary GI and higher dietary fiber
intake at the start and at the end of the intervention period. Both
of these suggest a healthier diet at baseline and greater treatment
fidelity during the intervention.
We hypothesized that infants born to mothers randomly
assigned to the HF diet would show increased adiposity per se at
birth, which would track throughout the first year of life.
However, body fat at birth and through the follow-up was similar
in both groups. There are several reasons that might account for
this null finding. First, although significant, the difference in the
dietary GI between the 2 groups was modest (51 6 1 in the low-
GI group compared with 57 6 1 in the HF group), with the HF
group consuming a diet that would usually be considered to be
medium-GI rather than high-GI. Participants were highly edu-
cated and potentially had knowledge of dietary GI and on the
importance of breastfeeding. In addition, normal neonatal body
composition has been shown in women who achieve good gly-
cemic control (37). In our sample, women in both groups, even
those with a diagnosis of GDM, achieved good glycemic control
(20). Last, it has been suggested that the effects of maternal
hyperglycemia on offspring growth and adiposity differ de-
pending on the age of the offspring. Differences have been
shown at birth (11, 34) and in early and mid-childhood (8, 38)
but not in infancy (39).
Finally, the ROLO study, an RCT of a low-GI diet in
pregnancy to prevent the recurrence of macrosomia, reported
significant positive effects of a modest lowering of dietary GI
and glycemic load on maternal gestational weight gain and
glucose tolerance (19). In the present study, we did not find
a significant effect of a low-GI diet on these variables. How-
ever, women enrolled in the randomized controlled trial of
a low glycemic index diet versus no dietary intervention to
prevent recurrence of fetal macrosomia (ROLO) study had
a higher BMI (w27 compared with w26) and had previously
delivered a macrosomic infant (.4000 g), suggesting that a
low-GI diet might be more beneficial for overweight and obese
pregnant women (40).
The strengths and weaknesses of our study should be noted. A
key component was the prospective cohort design and timely
assessment of growth and body composition from birth to 12 mo
of age, which provided unique information on the mechanisms
underlying links between maternal diet, blood glucose con-
centrations, and subsequent infant growth and adiposity. The
study had a low attrition rate (17%), which reduces bias and
increases the generalizability of the findings. The primary
limitations are those inherent to a self-selected group of vol-
unteers, including selection bias and confounding. Individuals
who participated in the follow-up study may differ in relevant
ways from those initially randomly assigned to the study. In
addition, other influences beyond the randomized diets may
have influenced the outcome. Only 56% of the eligible women
(n = 105) who completed the GI Baby 3 Study agreed to par-
ticipate in the follow-up study, which did not provide sufficient
power to detect some of the potentially important differences
between the groups, such as adiposity. Although we aimed for
a larger difference in GI between the 2 groups, the difference
achieved was modest (6 units). Vascular health was assessed by
using a single modality on a single occasion at 12 mo of age.
Furthermore, for aortic IMT we prospectively anticipated an
effect size of w25 mm, and therefore were underpowered in
this pilot study. Finally, residual confounding or selection bias
might have influenced the findings. Future larger trials are
required to confirm whether these improvements in arterial
wall thickness remain stable through childhood and into
adulthood and to ascertain whether other aspects of vascular
health, such as endothelial function and arterial stiffness, are
also improved.
In conclusion, this study showed that, in pregnant women at
risk of GDM, a low-GI diet resulted in lower offspring WAZ and
FIGURE 3 Effects of a low-GI compared with an HF diet during preg-
nancy on offspring aortic wall thickness at 12 mo of age. Error bars represent
10th and 90th percentiles, boxes represent 25th and 75th percentiles, and the
line represents the 50th percentile (median) of mean aortic intima-media
thickness (n = 40: 20 in the low-GI group and 20 in the HF group). GI,
glycemic index; HF, high-fiber.
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LAZ at birth but no difference in adiposity, weight gain, or growth
trajectory during the first 12 mo after birth. At 12 mo of age,
children whose mothers were randomly assigned to the low-GI
diet had lower aortic wall thickness. These findings suggest
a potential effect of dietary GI on fetal growth regulation and
offspring vascular health, but not adiposity, in infancy.
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